Adaptam Therapeutics
Adaptam’s approach focuses on disrupting the tumour microenvironment, which often prevents immune cells from effectively attacking cancer.
Adaptam Therapeutics has raised €3.0M across 1 funding round from 1 investor, most recently a Pre-Seed round in Oct 2025. Based in Barcelona, Spain; active in Healthtech. Data as of 28 Oct 2026.
Barcelona, Spainadaptamtx.com ↗
Total raised
€3.0M
€3,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2025-10
latest 2025-10
Funding by year
EUR raised per yearAdaptam Therapeutics — funding by year — interactive chart.
Data table
| Adaptam Therapeutics — funding by year | |
|---|---|
| 2025 | €3.0M |
Signals
High confidenceRaise-next likelihood34
base rate 24% for Pre-Seed
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-10-27 | Pre-Seed | €3.0M | Criteria Bio Ventures | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData